Tuesday, March 17, 2026

80-Year-Old Korean-Australian Reunites with Family in North Korea After Five-Year Hiatus

A private family reunion between separated relatives occurred for the first time in five years, highlighting inter-Korean dynamics.

Is South Korea the Most Vulnerable Emerging Market to U.S. Rate Hikes? Find Out!

South Korea is most vulnerable to U.S. interest rate shifts, with rising long-term yields impacting its bond market sensitivity.

Measles Outbreak: Why the U.S. Sees Highest Cases in 33 Years – What You Need to Know

Measles cases surge in the U.S. with a sevenfold increase in 2023, prompting health officials to urge vaccinations for travelers.

Tag: K-bio

Samsung Biologics Partners with Eli Lilly: How This Open Innovation Hub Will Transform K-Bio by 2027

Samsung Biologics partners with Eli Lilly to create a biotech innovation hub in Korea, enhancing growth opportunities for local firms.

CKDB-501A vs. Botox: Can CKD BiO’s New Botulinum Toxin Compete in China’s Booming Market?

Jongkundang Bio has successfully completed Phase 3 trials in China's botulinum toxin market, signaling global expansion.

Is DD01 the Future of MASH Treatment? Insights from D&D Pharmatech’s JP Morgan Presentation

D&D Pharmatech's CEO highlights growth in K-bio at JPM Healthcare Conference, unveiling promising drug data and future plans for clinical trials.

Top News

- Our Sponsors Ad -

Follow us